DK1761520T3 - Kinaseinhibitorer - Google Patents
KinaseinhibitorerInfo
- Publication number
- DK1761520T3 DK1761520T3 DK05766569T DK05766569T DK1761520T3 DK 1761520 T3 DK1761520 T3 DK 1761520T3 DK 05766569 T DK05766569 T DK 05766569T DK 05766569 T DK05766569 T DK 05766569T DK 1761520 T3 DK1761520 T3 DK 1761520T3
- Authority
- DK
- Denmark
- Prior art keywords
- kinase inhibitors
- formula
- present
- inhibitors
- provides kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04380131A EP1609789A1 (en) | 2004-06-23 | 2004-06-23 | Ureido-pyrazole derivatives and their use as kinase inhibitors |
US59253904P | 2004-07-30 | 2004-07-30 | |
EP04380174 | 2004-08-23 | ||
US62249204P | 2004-10-27 | 2004-10-27 | |
PCT/US2005/021148 WO2006009741A1 (en) | 2004-06-23 | 2005-06-15 | Kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1761520T3 true DK1761520T3 (da) | 2008-10-27 |
Family
ID=43875180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05766569T DK1761520T3 (da) | 2004-06-23 | 2005-06-15 | Kinaseinhibitorer |
Country Status (9)
Country | Link |
---|---|
US (1) | US7767674B2 (da) |
EP (1) | EP1761520B1 (da) |
AT (1) | ATE400567T1 (da) |
DK (1) | DK1761520T3 (da) |
ES (1) | ES2308523T3 (da) |
PL (1) | PL1761520T3 (da) |
PT (1) | PT1761520E (da) |
SI (1) | SI1761520T1 (da) |
WO (1) | WO2006009741A1 (da) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005089380A2 (en) | 2004-03-16 | 2005-09-29 | The Regents Of The University Of California | Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
WO2004089296A2 (en) | 2003-04-03 | 2004-10-21 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
CA2584342C (en) | 2004-10-20 | 2013-04-30 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
AR058128A1 (es) * | 2005-10-28 | 2008-01-23 | Lilly Co Eli | Compuesto de pirazolil carbamato y formulacion farmaceutica que lo comprende |
DOP2006000234A (es) * | 2005-10-28 | 2007-05-31 | Lilly Co Eli | Inhibidores de cinasa |
AR059826A1 (es) | 2006-03-13 | 2008-04-30 | Univ California | Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
US8236954B2 (en) * | 2007-06-26 | 2012-08-07 | Glaxosmithkline Llc | Processes for preparing benzimidazole thiophenes |
US8314091B2 (en) | 2007-08-20 | 2012-11-20 | Msd Oss B.V. | N-benzyl,N'-arylcarbonylpiperazine derivatives |
WO2009119534A1 (ja) | 2008-03-26 | 2009-10-01 | 第一三共株式会社 | 新規テトラヒドロイソキノリン誘導体 |
TW201022230A (en) * | 2008-08-28 | 2010-06-16 | Organon Nv | 1-(4-ureidobenzoyl)piperazine derivatives |
CN102256964A (zh) | 2008-10-02 | 2011-11-23 | 瑞斯比维特有限公司 | p38MAP激酶抑制剂 |
GB0818033D0 (en) | 2008-10-02 | 2008-11-05 | Respivert Ltd | Novel compound |
CA2746357A1 (en) | 2008-12-11 | 2010-06-17 | Respivert Limited | P38 map kinase inhibitors |
SG174134A1 (en) | 2009-02-17 | 2011-10-28 | Chiesi Farma Spa | Triazolopyridine derivatives as p38 map kinase inhibitors |
GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
JP2013506691A (ja) * | 2009-10-02 | 2013-02-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | ホスファチジルイノシトール3−キナーゼのピラゾール阻害薬 |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
WO2012054093A2 (en) | 2010-01-29 | 2012-04-26 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
GB201009731D0 (en) | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
MX351958B (es) | 2011-12-09 | 2017-11-06 | Chiesi Farm Spa | Inhibidores de cinasa. |
ME02624B (me) | 2011-12-09 | 2017-06-20 | Chiesi Farm Spa | Inhibitori kinaze |
US9150570B2 (en) * | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
KR20160018567A (ko) | 2013-06-06 | 2016-02-17 | 키에시 파르마슈티시 엣스. 피. 에이. | 키나아제 억제제 |
WO2017108736A1 (en) | 2015-12-23 | 2017-06-29 | Chiesi Farmaceutici S.P.A. | N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors |
EP3394059B1 (en) | 2015-12-23 | 2020-11-25 | Chiesi Farmaceutici S.p.A. | 1-(3-tert-butyl-phenyl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro- naphthalen-1-yl)-urea derivatives and their use as p38 mapk inhibitors |
MA43706B1 (fr) | 2016-03-17 | 2020-09-30 | Hoffmann La Roche | Dérivé de 5-éthyl-4-méthyl-pyrazole-3-carboxamide ayant une activité en tant qu'agoniste de taar |
CN107619388A (zh) | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
CN107840842A (zh) | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
WO2019071144A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
TR200102817T2 (tr) | 1999-03-12 | 2002-05-21 | Boehringer Ingelheim Pharmaceuticals, Inc. | Antiinflamatuar ajanlar olarak faydalı bileşikler |
EP1480973B1 (en) * | 2002-02-25 | 2008-02-13 | Boehringer Ingelheim Pharmaceuticals Inc. | 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
GB0320244D0 (en) | 2003-05-06 | 2003-10-01 | Aventis Pharma Inc | Pyrazoles as inhibitors of tumour necrosis factor |
US20070010529A1 (en) * | 2003-05-19 | 2007-01-11 | Kanji Takahashi | Nitrogenous heterocyclic compounds and medical use thereof |
-
2005
- 2005-06-15 WO PCT/US2005/021148 patent/WO2006009741A1/en not_active Application Discontinuation
- 2005-06-15 PL PL05766569T patent/PL1761520T3/pl unknown
- 2005-06-15 PT PT05766569T patent/PT1761520E/pt unknown
- 2005-06-15 AT AT05766569T patent/ATE400567T1/de not_active IP Right Cessation
- 2005-06-15 ES ES05766569T patent/ES2308523T3/es active Active
- 2005-06-15 EP EP05766569A patent/EP1761520B1/en active Active
- 2005-06-15 DK DK05766569T patent/DK1761520T3/da active
- 2005-06-15 SI SI200530351T patent/SI1761520T1/sl unknown
- 2005-06-15 US US11/569,809 patent/US7767674B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20080306068A1 (en) | 2008-12-11 |
PL1761520T3 (pl) | 2008-12-31 |
PT1761520E (pt) | 2008-09-15 |
EP1761520B1 (en) | 2008-07-09 |
ATE400567T1 (de) | 2008-07-15 |
SI1761520T1 (sl) | 2008-10-31 |
US7767674B2 (en) | 2010-08-03 |
WO2006009741A1 (en) | 2006-01-26 |
ES2308523T3 (es) | 2008-12-01 |
EP1761520A1 (en) | 2007-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1761520T3 (da) | Kinaseinhibitorer | |
ATE346070T1 (de) | Purinderivate als kinaseinhibitoren | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
CY1109234T1 (el) | Αναστολεις κινασης | |
EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
SMT201300109B (it) | Imidazopiridazincarbonitrili utili come inibitori di chinasi | |
TW200640924A (en) | VEGF-R2 inhibitors and methods | |
NO20065148L (no) | Monocykliske heterocykler som kinase inhibitorer | |
CR20120421A (es) | Compuestos de aminohetetoarilo o sustituidos con pirazol como inhibidores de proteina quinasa | |
NO20071127L (no) | Triazoloftalaziner | |
NO20081636L (no) | FAP - inhibitorer | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
EA200801199A1 (ru) | Ингибиторы киназы | |
UY29612A1 (es) | Compuestos quimicos ii | |
EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
NI201000059A (es) | Inhibidores de la cinasa c-fms. | |
DE602005025733D1 (de) | Pyrazolopyrimidinderivate als inhibitoren der cyclinabhängigen kinase | |
EA200870409A1 (ru) | Антагонисты киназы pi3 | |
IL163777A0 (en) | Kinase inhibitors | |
EA200501928A1 (ru) | Пирролодигидроизохинолины как ингибиторы pde10 | |
EA201170680A1 (ru) | Ингибиторы акт и p70 s6-киназы | |
EA201200891A1 (ru) | Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина | |
EA200801200A1 (ru) | ПРОИЗВОДНЫЕ ПИРАЗОЛИЗОХИНОЛИНМОЧЕВИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ p38 КИНАЗЫ | |
EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
EA200800070A1 (ru) | Производные 2-(1h-индолилсульфанил)ариламина |